[RGLS] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
09-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 61.93%
YoY- 79.66%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 0 0 6 6,778 18 18 489 -
PBT -6,718 -6,013 -5,945 -3,260 -16,024 -20,025 -21,212 -17.43%
Tax 1 -335 -8 56 1 -4 -5 -
NP -6,719 -6,013 -5,937 -3,260 -16,025 -20,021 -21,207 -17.42%
Tax Rate - - - - - - - -
Total Cost 6,719 6,013 5,943 10,038 16,043 20,039 21,696 -17.73%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 0.00 0.00 -98,950.00 -48.10 -89,027.78 -111,227.78 -4,336.81 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.46 -0.84 -2.47 -3.14 -18.49 -45.34 -48.28 -53.94%
EPS Diluted -0.46 -0.84 -2.47 -3.14 -18.49 -45.34 -48.28 -53.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.